These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20231901)

  • 21. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
    Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
    Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possibility of adoptive immunotherapy with peripheral blood-derived CD3⁻CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity.
    Doskali M; Tanaka Y; Ohira M; Ishiyama K; Tashiro H; Chayama K; Ohdan H
    J Immunother; 2011 Mar; 34(2):129-38. PubMed ID: 21304407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.
    Barnaba V; Franco A; Paroli M; Benvenuto R; De Petrillo G; Burgio VL; Santilio I; Balsano C; Bonavita MS; Cappelli G
    J Immunol; 1994 Mar; 152(6):3074-87. PubMed ID: 7511637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders.
    Martinez D; Palmer C; Simar D; Cameron BA; Nguyen N; Aggarwal V; Lloyd AR; Zekry A
    Liver Int; 2015 Feb; 35(2):463-72. PubMed ID: 24461080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
    Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
    Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
    Brand S; Dambacher J; Beigel F; Zitzmann K; Heeg MH; Weiss TS; Prüfer T; Olszak T; Steib CJ; Storr M; Göke B; Diepolder H; Bilzer M; Thasler WE; Auernhammer CJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1019-28. PubMed ID: 17204547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals.
    Montoya CJ; Velilla PA; Chougnet C; Landay AL; Rugeles MT
    Clin Immunol; 2006 Aug; 120(2):138-46. PubMed ID: 16624619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of STATs and their inhibitors SOCS and PIAS in brain tumors. In vitro and in vivo study.
    Ehrmann J; Strakova N; Vrzalikova K; Hezova R; Kolar Z
    Neoplasma; 2008; 55(6):482-7. PubMed ID: 18999875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro.
    Kelly-Rogers J; Madrigal-Estebas L; O'Connor T; Doherty DG
    Hum Immunol; 2006 Nov; 67(11):863-73. PubMed ID: 17145366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes.
    Larrea E; Riezu-Boj JI; Aldabe R; Guembe L; Echeverria I; Balasiddaiah A; Gastaminza P; Civeira MP; Sarobe P; Prieto J
    Gut; 2014 Apr; 63(4):665-73. PubMed ID: 23787026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
    Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals.
    Kanto T; Hayashi N; Takehara T; Tatsumi T; Kuzushita N; Ito A; Sasaki Y; Kasahara A; Hori M
    J Immunol; 1999 May; 162(9):5584-91. PubMed ID: 10228041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional control of impaired Th1 responses in patent lymphatic filariasis by T-box expressed in T cells and suppressor of cytokine signaling genes.
    Babu S; Kumaraswami V; Nutman TB
    Infect Immun; 2005 Jun; 73(6):3394-401. PubMed ID: 15908366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells.
    Heller NM; Matsukura S; Georas SN; Boothby MR; Rothman PB; Stellato C; Schleimer RP
    Am J Respir Cell Mol Biol; 2004 Nov; 31(5):573-82. PubMed ID: 15297269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.
    el-Kady IM; el-Masry SA; Badra G; Halafawy KA
    Egypt J Immunol; 2004; 11(1):23-9. PubMed ID: 15724383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma.
    Yao ZQ; Ni L; Zhang Y; Ma CJ; Zhang CL; Dong ZP; Frazier AD; Wu XY; Thayer P; Borthwick T; Chen XY; Moorman JP
    Immunol Invest; 2011; 40(3):243-64. PubMed ID: 21291295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.
    Basu A; Meyer K; Ray RB; Ray R
    Virology; 2001 Sep; 288(2):379-90. PubMed ID: 11601909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.